Platelet reactivity in stable cardiovascular patients with chronic kidney disease

Platelet reactivity in stable cardiovascular patients with chronic kidney disease

The study aimed to evaluate antiplatelet drug responsiveness in stable outpatients with cardiovascular disease and chronic kidney disease (CKD) and examine whether impaired antiplatelet drug responsiveness is associated with worse clinical outcomes in this population. Stable cardiovascular patients...

Full description

Bibliographic Details
Main Authors:	Thomas A. Mavrakanas, Ahsan Alam, Jean-Luc Reny, Pierre Fontana
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2018-07-01
Series:	Platelets
Subjects:	aspirin chronic kidney disease clopidogrel high platelet reactivity major adverse cardiovascular events
Online Access:	http://dx.doi.org/10.1080/09537104.2017.1316485

Similar Items

ANTIAGGREGANT THERAPY AND REDUCTION OF HIGH RESIDUAL PLATELET REACTIVITY
by: N. A. Mazur, et al.
Published: (2012-08-01)

Prevalence of high on-treatment platelet reactivity in patients after percutaneous coronary intervention
by: Dušan Avramović
Published: (2016-07-01)

Rivaroxaban reduces thromboxane induced platelet aggregation - the forgotten compass arm?
by: Lisa Dannenberg, et al.
Published: (2021-11-01)

Cardiovascular Prevention in People Living With HIV
by: Johanne Silvain, MD, PhD, et al.
Published: (2022-11-01)

Assessment of efficacy of single dose acetylsalicylic acid over a 24-hour period
by: Reşat Mehmet Baha, et al.
Published: (2015-07-01)

Pharmacodynamic effects of a new fixed-dose clopidogrel–aspirin combination compared with separate administration of clopidogrel and aspirin in patients treated with coronary stents: The ACCEL-COMBO trial
by: Jin-Sin Koh, et al.
Published: (2017-02-01)

Combined with ticagrelor, 50 mg aspirin daily can reduce bleeding events without increasing ischemic risk compared with 75–100 mg aspirin daily in coronary artery disease patients: insights from the TIFU (Ticagrelor in Fuwai Hospital) study
by: Jiannan Li, et al.
Published: (2020-08-01)

Modifying effect of diabetes on the short-term effect of clopidogrel in patients with myocardial infarction
by: Wuxiang Xie, et al.
Published: (2018-01-01)

Association between renal function and platelet reactivity during aspirin therapy in elderly patients with atherosclerotic cardiovascular disease
by: Wenyi Liang, et al.
Published: (2021-01-01)

Effects of Monotherapy with Clopidogrel vs. Aspirin on Vascular Function and Hemostatic Measurements in Patients with Coronary Artery Disease: The Prospective, Crossover I-LOVE-MONO Trial
by: Hyun-Woong Park, et al.
Published: (2021-06-01)

Antiplatelet Effects of Clopidogrel Vs Aspirin in Virologically Controlled HIV
by: Emanuela Marcantoni, PhD, et al.
Published: (2022-11-01)

Effect of cytochrome P450 2C19*17 allelic variant on cardiovascular and cerebrovascular outcomes in clopidogrel-treated patients: A systematic review and meta-analysis
by: Bo Huang, et al.
Published: (2017-01-01)

Diurnal variations in tissue factor and tissue factor pathway inhibitor concentrations in relation to on-treatment platelet reactivity: an analysis of patients with acute myocardial infarction
by: Joanna Boinska, et al.
Published: (2020-10-01)

Dual antiplatelet therapy is associated with high α-tubulin acetylation in circulating platelets from coronary artery disease patients
by: Valentine Robaux, et al.
Published: (2023-12-01)

EVALUATION OF PLATELET AGGREGATION IN CLINICAL PRACTICE
by: K. B. Mirzaev, et al.
Published: (2015-09-01)

vWF/ADAMTS13 is associated with on-aspirin residual platelet reactivity and clinical outcome in patients with stable coronary artery disease
by: Ellen M. K. Warlo, et al.
Published: (2017-11-01)

Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups
by: Georg Gelbenegger, et al.
Published: (2019-11-01)

The Phenomenon of Clopidogrel High On-Treatment Platelet Reactivity in Ischemic Stroke Subjects: A Comprehensive Review
by: Adam Wiśniewski, et al.
Published: (2020-09-01)

Ticagrelor Is Superior to Clopidogrel in Inhibiting Platelet Reactivity in Patients With Minor Stroke or TIA
by: Yingying Yang, et al.
Published: (2020-06-01)

Excess Risk of Major Adverse Cardiovascular and Kidney Events after Acute Kidney Injury following Living Donor Liver Transplantation
by: Yi-Chia Chan, et al.
Published: (2022-05-01)

Effectiveness of Platelet Function Analysis-Guided Aspirin and/or Clopidogrel Therapy in Preventing Secondary Stroke: A Systematic Review and Meta-Analysis
by: Ann-Rong Yan, et al.
Published: (2020-12-01)

Predictors of high on-aspirin platelet reactivity in elderly patients with coronary artery disease
by: Zhang JW, et al.
Published: (2017-08-01)

Impact of Proton Pump Inhibitor Use on the Comparative Effectiveness and Safety of Prasugrel Versus Clopidogrel: Insights From the Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE‐ACS) Study
by: Larry R. Jackson, et al.
Published: (2016-10-01)

Post percutaneous coronary interventional adverse cardiovascular outcomes and bleeding events observed with prasugrel versus clopidogrel: direct comparison through a meta-analysis
by: Pravesh Kumar Bundhun, et al.
Published: (2018-05-01)

Anti-platelet Therapy Resistance – Concept, Mechanisms and Platelet Function Tests in Intensive Care Facilities
by: Mărginean Alina, et al.
Published: (2016-01-01)

Factors influencing platelet aggregation in patients with acute coronary syndrome
by: A V Mazurov, et al.
Published: (2014-09-01)

The role of clopidogrel resistance-related genetic and epigenetic factors in major adverse cardiovascular events among patients with acute coronary syndrome after percutaneous coronary intervention
by: Astuti Giantini, et al.
Published: (2023-02-01)

Aspirin vs. P2Y12 Inhibitor Rivalry: Which One Can be Continued During Gastrointestinal Bleeding
by: Muhammad Begawan Bestari, et al.
Published: (2019-11-01)

The Effect of Low-Dose Ticagrelor on Platelet Function Profiles in Patients With Stable Coronary Artery Disease in Trinidad: The TWIST Pilot Study
by: Naveen Seecheran, et al.
Published: (2020-08-01)

Platelet reactivity-adjusted antiplatelet therapy in patients with percutaneous coronary intervention: a meta-analysis of randomized controlled trials
by: Zhenhua Xing, et al.
Published: (2018-08-01)

ROLE OF THE ANTIPLATELET DRUGS IN TREATMENT OF STABLE ANGINA: COMMON SENSE AND NON-RESOLVED ISSUES
by: V. V. Yakusevich, et al.
Published: (2015-07-01)

Influence of Sex on Platelet Reactivity in Response to Aspirin
by: Kevin A. Friede, et al.
Published: (2020-07-01)

The efficacy of clopidogrel in preventing recurrent cardiovascular events among Arab population carrying different CYP2C19 mutations: systematic review and meta-analysis
by: Abdullah N. Alkattan, et al.
Published: (2022-06-01)

TRimetazidine as an Agent to affeCt clopidogrEl Response: The TRACER Study
by: Naveen Seecheran, et al.
Published: (2019-07-01)

Comparison of administration of clopidogrel with aspirin versus aspirin alone in prevention of secondary stroke after transient ischemic attack
by: Mojtaba Khazaei, et al.
Published: (2019-03-01)

Similar Inflammatory Biomarkers Reflect Different Platelet Reactivity in Percutaneous Coronary Intervention Patients Treated With Clopidogrel: A Large-Sample Study From China
by: Jiawen Li, et al.
Published: (2021-10-01)

Elevated Baseline Serum Fibrinogen: Effect on 2‐Year Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention
by: Lawrence Ang, et al.
Published: (2017-11-01)

RESIDUAL PLATELET REACTIVITY DURING THERAPY WITH INHIBITORS OF CYCLOOXIGENASE OR ADENOSINE DIPHOSPHATE RECEPTORS
by: A. A. Lomonosova, et al.
Published: (2015-12-01)

Comparison of In-Hospital Major Adverse Cardiovascular Events in Patients with Acute Myocardial Infarction Treated with Ticagrelor or Clopidogrel in the Emergency Department: A Propensity Score Matched Retrospective Cohort Study
by: Po-Yao Huang, et al.
Published: (2023-08-01)

High On-Treatment Platelet Reactivity in Danish Hyper-Acute Ischaemic Stroke Patients
by: Charlotte L. Rath, et al.
Published: (2018-08-01)